10 resultats
BACKGROUND OF THE INVENTION
This invention relates to biochemistry and more particularly to an enzymatic preparation for the control of tumor growth and immune diseases, and a process of administering said preparation to mammals.
This invention further relates to a process for suppressing the immune
Throughout this application, various publications are referenced by author and date. Full citations for these publications may be found listed alphabetically at the end of the specification immediately before the claims. The disclosures of these publications in their entireties are hereby
BACKGROUND OF THE INVENTION
This invention relates to biochemistry and more particularly to an enzymatic preparation for the control of tumor growth and immune diseases, and a process of inserting said preparation into mammals.
Ample evidence has shown that the combination of certain peroxidases
FIELD OF THE INVENTION
The present invention relates to hydrogel formation, particularly to formation of hydrogels in the presence of peroxidase and hydrogen peroxide.
BACKGROUND OF THE INVENTION
Phenol-containing hydrogels, such as hyaluronic acid-tyramine (HA-Tyr) hydrogels, are useful in many
CROSS-REFERENCE TO RELATED APPLICATIONS
This is a 371 of PCT/EP2003/009229, filed 20 Aug. 2003 which claims priority from German Patent Application No. 102 38 046.5 filed 20 Aug. 2002.
TECHNICAL FIELD
The present invention relates to a method for investigating body fluids for cancer cells, the use
BACKGROUND OF THE INVENTION
The present invention relates to a method for differentiating the source of occult gastrointestinal bleeding.
The common screening test for occult gastrointestinal bleeding is to test for fecal occult blood (FOB). An FOB test involves placing a sample of stool onto a
FIELD OF THE INVENTION
Generally, the present invention relates to a diagnostic procedure and clinical test kit for determining the presence or absence of human chorionic gonadotropin hormone, a glycoprotein, in a cell specimen and thereby the absence of malignant neoplastic cells.
The reason why a
FIELD OF THE INVENTION
Generally, the present invention relates to a diagnostic procedure and clinical test kit for determining the presence or absence of human chorionic gonadotropin hormone, a glycoprotein, in a cell specimen and thereby the absence of malignant neoplastic cells.
The reason why a
FIELD OF THE INVENTION
The present invention relates to the use of stabilized peptide fragments derived from "redoxin proteins" as early or late stage cancer biomarkers. Such biomarkers can be used to determine a diagnosis or prognosis, or to assess the effectiveness of a therapeutic
FIELD OF THE INVENTION
The present invention relates generally to immunological testing methods, and more particularly to such methods for detection of antibodies against a chorionic gonadotropin-like substance.
SUMMARY OF THE INVENTION
The present invention comprises a method of detecting the